Mentari Therapeutics: TD Cowen initiates coverage with buy rating
MTRI•TD Cowen initiated coverage of Mentari Therapeutics with a buy rating.
Related News
Akzo Nobel and Axalta considering UK CMA Phase 1 decision on proposed merger
AXTA•
J.P. Morgan Securities cuts GnCenergy stake to 3.64% from 5.07%
JPM•
German October inflation confirmed at 2.8%
EWG•
Block, Inc.: Bernstein raises target price to $110 from $95
XYZ•
India approves high-capacity power corridor to support clean energy boom
INDA•